Sen. Hatch’s Generic Fix: Limits On 180-Day Marketing Exclusivity Proposed

Sen. Orrin Hatch (R-Utah) is proposing further reforms to Waxman/Hatch that would eliminate the 180-day marketing exclusivity award to the first ANDA filer in certain circumstances

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet